Amyloid formation plays an important role in a broad range of diseases and the search for amyloid inhibitors is an active area of research. Amyloid formation takes places in a heterogeneous environment in vivo with the potential for interactions with membranes and with components of the extracellular matrix. Naturally occurring amyloid deposits are associated with sulfated proteoglycans and other factors. However, the vast majority of in vitro assays of amyloid formation and amyloid inhibition are conducted in homogeneous solution where the potential for interactions with membranes or sulfated proteoglycans is lacking and it is possible that different results may be obtained in heterogeneous environments. We show that variants of islet amyloid polypeptide, which are non-amyloidgenic in homogeneous solution, can be readily induced to form amyloid in the presence of glycosaminoglycans. Glycosaminoglycans are found to be more effective than anionic lipid vesicles at inducing amyloid formation on a per charge basis. Several known inhibitors of IAPP amyloid formation are shown to be less effective in the presence of glycosaminoglycans.